In these studies, vaccines often encode well-characterized antigens, for example, HER2 or Mam-A in breast cancer, PAP in prostate cancer, and HPV-derived E6/E7 oncoproteins in cervical cancer [126]. This evidence concerns the gene ERBB2 and breast carcinoma.